Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rachel A. Farrell"'
Autor:
Paul I. Creeke, Rachel A. Farrell
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 6 (2013)
Biopharmaceuticals are drugs which are based on naturally occurring proteins (antibodies, receptors, cytokines, enzymes, toxins), nucleic acids (DNA, RNA) or attenuated microorganisms. Immunogenicity of these agents has been commonly described and re
Externí odkaz:
https://doaj.org/article/1c5d37358c09457396738edc9a99d6da
Publikováno v:
Journal of Contextual Behavioral Science. 28:139-148
Publikováno v:
Mental Health, Religion & Culture. :1-18
Publikováno v:
Mental Health, Religion & Culture. 25:462-478
Publikováno v:
Mental Health, Religion & Culture. 23:857-873
Rates of depression in Christian clergy have been reported as being more than three times that of the general population, and some studies have suggested this is associated with a lack of perceived...
Publikováno v:
Journal of clinical psychology. 78(9)
To systematically review evidence regarding prevalence and choices of disclosure of psychological distress, by mental health professionals within the workplace.Six databases were searched in June 2020. Studies were included if they were published in
Autor:
Andrea Stennett, Ashok Adams, Amy MacDougall, Eli Silber, Gavin Giovannoni, Luca Peruzzotti-Jametti, Lucia Bianchi, Sharmilee Gnanapavan, Zhifeng Mao, Owen R Pearson, Cris S. Constantinescu, K. Allen-Philbey, Özlem Yildiz, Basil Sharrack, Cesar Álvarez-González, Bruno Gran, Catherine Dalton, Klaus Schmierer, Christine Chapman, Z Khaleeli, Helen Ford, Camilla Blain, Antonio Scalfari, Leonora Fisniku, Stefania De Trane, Sue Pavitt, Gunnar Juliusson, Stewart Webb, Rachel A Farrell, Monica Marta, Miriam Mattoscio, Xia Zhou, Jeremy Hobart, David Baker, Emma C. Tallantyre, Joela Mathews, Karen Chung, Benjamin Turner
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Objective: To report on safety and effectiveness of subcutaneous cladribine (Litak®) in multiple sclerosis (MS) patients. Methods: Litak® was offered to MS-patients irrespective of disease course. Litak® 10 mg was administered for 3–4 days durin
Background – The remote delivery of psychotherapy via secure video link— videoconferencing psychotherapy (VCP)— has the potential to overcome many of the regularly cited barriers to accessing psychological treatment and is becoming more recogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbb95eb647410676a29c23ccd2d2800
Publikováno v:
Mental Health Review Journal. 24:51-68
Purpose The purpose of this paper is to systematically identify, appraise and synthesise qualitative literature exploring the experience, both positive and negative, of clinical supervision from the supervisor’s perspective. Design/methodology/appr
Autor:
Rachel A Farrell
Publikováno v:
Advances in Clinical Neuroscience & Rehabilitation.
Spasticity is a frequent symptom in people with Multiple Sclerosis. Whilst many respond to first-line therapies it is estimated that 30-40% will have suboptimal treatment response requiring more specialised management. Such strategies include combina